Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $846.40 | 24 | 88.0% |
| Education | $115.22 | 2 | 12.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $243.94 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $138.72 | 6 | $0 (2024) |
| Lilly USA, LLC | $125.00 | 1 | $0 (2017) |
| Celgene Corporation | $100.00 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $60.81 | 1 | $0 (2017) |
| Incyte Corporation | $47.19 | 2 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $35.53 | 2 | $0 (2020) |
| GENZYME CORPORATION | $27.91 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $27.66 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $252.75 | 7 | SANOFI-AVENTIS U.S. LLC ($99.95) |
| 2023 | $49.51 | 2 | Regeneron Healthcare Solutions, Inc. ($34.24) |
| 2022 | $80.12 | 3 | Regeneron Healthcare Solutions, Inc. ($52.44) |
| 2021 | $26.16 | 1 | AbbVie Inc. ($26.16) |
| 2020 | $35.37 | 2 | Novartis Pharmaceuticals Corporation ($20.42) |
| 2019 | $89.30 | 5 | AbbVie, Inc. ($36.76) |
| 2018 | $20.58 | 1 | Sun Pharmaceutical Industries Inc. ($20.58) |
| 2017 | $407.83 | 5 | Lilly USA, LLC ($125.00) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $27.66 | General |
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Dermatology | ||||||
| 04/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Dermatology | ||||||
| 01/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Immunology | ||||||
| 05/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/10/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 06/09/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/18/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: IMMUNOLOGY | ||||||
| 02/04/2020 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Dermatology | ||||||
| 01/21/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 05/28/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: DERMATOLOGY | ||||||
| 05/08/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/06/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/15/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Immunology | ||||||
| 10/09/2018 | Sun Pharmaceutical Industries Inc. | ILUMYA (tildrakizumab-asmn) injection (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Dermatology | ||||||
| 09/21/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $112.38 | General |
| Category: Immunology | ||||||
| 05/18/2017 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/14/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Immunology | ||||||
| 03/04/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,242 | 2,194 | $473,244 | $137,978 |
| 2022 | 11 | 945 | 2,073 | $329,736 | $105,673 |
| 2021 | 10 | 905 | 2,094 | $313,126 | $100,762 |
| 2020 | 14 | 1,036 | 1,947 | $320,472 | $89,162 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 429 | $156,156 | $47,254 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 225 | $55,575 | $16,661 | 30.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 194 | 307 | $61,985 | $16,122 | 26.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 97 | 128 | $35,658 | $14,559 | 40.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 109 | 138 | $46,128 | $12,957 | 28.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 146 | 731 | $15,351 | $5,246 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $18,836 | $4,802 | 25.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 14 | $18,970 | $4,382 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $17,885 | $3,881 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $9,291 | $2,520 | 27.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 16 | $7,184 | $2,031 | 28.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 38 | $9,158 | $1,979 | 21.6% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 11 | 12 | $6,972 | $1,920 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 40 | $6,160 | $1,877 | 30.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $7,935 | $1,787 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 297 | $104,841 | $33,694 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 227 | $54,480 | $18,135 | 33.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 173 | 300 | $57,720 | $16,069 | 27.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 78 | 107 | $28,274 | $12,148 | 43.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 77 | 95 | $31,947 | $9,437 | 29.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 146 | 946 | $19,866 | $6,876 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $10,222 | $2,817 | 27.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $9,204 | $2,400 | 26.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 13 | 13 | $5,538 | $1,774 | 32.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 27 | $3,996 | $1,458 | 36.5% |
About Monica Sandhu
Monica Sandhu is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1649698614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Monica Sandhu has received a total of $961.62 in payments from pharmaceutical and medical device companies, with $252.75 received in 2024. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($846.40).
As a Medicare-enrolled provider, Sandhu has provided services to 4,128 Medicare beneficiaries, totaling 8,308 services with total Medicare billing of $433,575. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 04/07/2014
- Last Updated 06/03/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1649698614
Products in Payments
- DUPIXENT (Biological) $266.58
- Humira (Biological) $158.78
- Otezla (Drug) $100.00
- SKYRIZI (Biological) $57.48
- OPZELURA (Drug) $47.19
- RINVOQ (Biological) $27.68
- ILUMYA (tildrakizumab-asmn) injection (Biological) $20.58
- COSENTYX (Biological) $20.42
- SILIQ (Drug) $19.22
- CIBINQO (Drug) $15.27
- ILUMYA (Biological) $14.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860